NO20010567L - Zonulinpeptidantagonister og fremgangsmÕter for anvendelse av disse - Google Patents

Zonulinpeptidantagonister og fremgangsmÕter for anvendelse av disse

Info

Publication number: NO20010567L
Authority: NO; Norway
Prior art keywords: peptide antagonists; methods; zonulin; zonulin peptide; opening
Prior art date: 1998-08-03

Application number

NO20010567A

Other languages

English (en)

Other versions

NO326552B1 (no

NO20010567D0 (no

Inventor

Alessio Fasano

Original Assignee

Univ Maryland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-03

Filing date

2001-02-02

Publication date

2001-04-02

2001-02-02 Application filed by Univ Maryland filed Critical Univ Maryland

2001-02-02 Publication of NO20010567D0 publication Critical patent/NO20010567D0/no

2001-04-02 Publication of NO20010567L publication Critical patent/NO20010567L/no

2009-01-05 Publication of NO326552B1 publication Critical patent/NO326552B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Oncology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20010567A 1998-08-03 2001-02-02 Peptidantagonist av zonulin, anvendelse av et peptid som motvirker apning av tette celle-celleforbindelser ved fremstilling av et medikament for behandling av inflammasjon i mage-tarmkanalen, peptid samt anvendelse av peptidet for fremstilling av et medikament. NO326552B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/127,815 US6458925B1 (en)	1998-08-03	1998-08-03	Peptide antagonists of zonulin and methods for use of the same
PCT/US1999/016683 WO2000007609A1 (en)	1998-08-03	1999-07-28	Peptide antagonists of zonulin and methods for use of the same

Publications (3)

Publication Number	Publication Date
NO20010567D0 NO20010567D0 (no)	2001-02-02
NO20010567L true NO20010567L (no)	2001-04-02
NO326552B1 NO326552B1 (no)	2009-01-05

Family

ID=22432094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010567A NO326552B1 (no)	1998-08-03	2001-02-02	Peptidantagonist av zonulin, anvendelse av et peptid som motvirker apning av tette celle-celleforbindelser ved fremstilling av et medikament for behandling av inflammasjon i mage-tarmkanalen, peptid samt anvendelse av peptidet for fremstilling av et medikament.

Country Status (18)

Country	Link
US (10)	US6458925B1 (no)
EP (2)	EP1102596B1 (no)
JP (1)	JP4822585B2 (no)
KR (1)	KR100610389B1 (no)
CN (2)	CN1217697C (no)
AT (2)	ATE480252T1 (no)
AU (1)	AU745507B2 (no)
CA (1)	CA2338005C (no)
DE (2)	DE69931929T2 (no)
DK (1)	DK1102596T3 (no)
ES (1)	ES2267282T3 (no)
HU (1)	HU228079B1 (no)
IL (2)	IL141082A0 (no)
NO (1)	NO326552B1 (no)
NZ (1)	NZ509579A (no)
RU (1)	RU2214267C2 (no)
WO (1)	WO2000007609A1 (no)
ZA (1)	ZA200100829B (no)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458925B1 (en) *	1998-08-03	2002-10-01	University Of Maryland, Baltimore	Peptide antagonists of zonulin and methods for use of the same
WO2001089551A1 (en) *	2000-05-19	2001-11-29	University Of Maryland, Baltimore	Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
US7452877B2 (en)	2002-03-15	2008-11-18	Rytek	Methods for treating digestive functional pathologies
FR2844201A1 (fr) *	2002-09-06	2004-03-12	Rytek	Compositions pour le traitement de pathologies fonctionnelles digestives
KR100858553B1 (ko) *	2003-07-15	2008-09-12	유니버시티 오브 메릴랜드, 볼티모어	Ｚｏｔ 및 조눌린에 대한 수용체의 작용제 폴리펩티드
US7067385B2 (en)	2003-09-04	2006-06-27	Micron Technology, Inc.	Support for vertically oriented capacitors during the formation of a semiconductor device
US7125781B2 (en) *	2003-09-04	2006-10-24	Micron Technology, Inc.	Methods of forming capacitor devices
US20080038843A1 (en) *	2006-08-11	2008-02-14	University Of Maryland - Baltimore	Method of diagnosing celiac disease
US7387939B2 (en) *	2004-07-19	2008-06-17	Micron Technology, Inc.	Methods of forming semiconductor structures and capacitor devices
US7202127B2 (en) *	2004-08-27	2007-04-10	Micron Technology, Inc.	Methods of forming a plurality of capacitors
US7439152B2 (en) *	2004-08-27	2008-10-21	Micron Technology, Inc.	Methods of forming a plurality of capacitors
US20060046055A1 (en)	2004-08-30	2006-03-02	Nan Ya Plastics Corporation	Superfine fiber containing grey dope dyed component and the fabric made of the same
US7547945B2 (en)	2004-09-01	2009-06-16	Micron Technology, Inc.	Transistor devices, transistor structures and semiconductor constructions
US7320911B2 (en) *	2004-12-06	2008-01-22	Micron Technology, Inc.	Methods of forming pluralities of capacitors
FR2879100B1 (fr)	2004-12-09	2007-07-06	Lionel Bueno	Compositions pour le traitement des pathologies oculaires de surface et de la retine
TW200637573A (en) *	2005-01-14	2006-11-01	Univ Maryland	Peptide for delivery of mucosal vaccines
US7557015B2 (en)	2005-03-18	2009-07-07	Micron Technology, Inc.	Methods of forming pluralities of capacitors
GB2425654B (en) *	2005-04-29	2010-03-17	Seiko Epson Corp	A method of fabricating a heterojunction of organic semiconducting polymers
EP1722466A1 (en) *	2005-05-13	2006-11-15	STMicroelectronics S.r.l.	Method and relative circuit for generating a control voltage of a synchronous rectifier
US7517753B2 (en) *	2005-05-18	2009-04-14	Micron Technology, Inc.	Methods of forming pluralities of capacitors
US7544563B2 (en)	2005-05-18	2009-06-09	Micron Technology, Inc.	Methods of forming a plurality of capacitors
TW200716159A (en) *	2005-06-09	2007-05-01	Univ Maryland	Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
US7282401B2 (en)	2005-07-08	2007-10-16	Micron Technology, Inc.	Method and apparatus for a self-aligned recessed access device (RAD) transistor gate
US7199005B2 (en) *	2005-08-02	2007-04-03	Micron Technology, Inc.	Methods of forming pluralities of capacitors
US7867851B2 (en)	2005-08-30	2011-01-11	Micron Technology, Inc.	Methods of forming field effect transistors on substrates
US7700441B2 (en)	2006-02-02	2010-04-20	Micron Technology, Inc.	Methods of forming field effect transistors, methods of forming field effect transistor gates, methods of forming integrated circuitry comprising a transistor gate array and circuitry peripheral to the gate array, and methods of forming integrated circuitry comprising a transistor gate array including first gates and second grounded isolation gates
EP2777695B1 (en) *	2006-02-09	2018-09-12	Alba Therapeutics Corporation	Formulations for a tight junction effector
US7557013B2 (en)	2006-04-10	2009-07-07	Micron Technology, Inc.	Methods of forming a plurality of capacitors
US7602001B2 (en)	2006-07-17	2009-10-13	Micron Technology, Inc.	Capacitorless one transistor DRAM cell, integrated circuitry comprising an array of capacitorless one transistor DRAM cells, and method of forming lines of capacitorless one transistor DRAM cells
US7772632B2 (en)	2006-08-21	2010-08-10	Micron Technology, Inc.	Memory arrays and methods of fabricating memory arrays
US7589995B2 (en)	2006-09-07	2009-09-15	Micron Technology, Inc.	One-transistor memory cell with bias gate
US20090069247A1 (en) *	2006-10-06	2009-03-12	Blake Paterson	Use of tight junction antagonists to treat inflammatory bowel disease
US7902081B2 (en)	2006-10-11	2011-03-08	Micron Technology, Inc.	Methods of etching polysilicon and methods of forming pluralities of capacitors
US8034776B2 (en)	2006-10-26	2011-10-11	Alba Therapeutics Corporation	Materials and methods for the treatment of celiac disease
WO2008073627A2 (en)	2006-11-03	2008-06-19	Alba Therapeutics Corporation	Method of diagnosing and treating asthma
US7785962B2 (en)	2007-02-26	2010-08-31	Micron Technology, Inc.	Methods of forming a plurality of capacitors
US8728491B2 (en) *	2007-05-07	2014-05-20	Alba Therapeutics Corporation	Transcutaneous delivery of therapeutic agents
WO2008150981A2 (en) *	2007-05-30	2008-12-11	Alba Therapeutics Corporation	Novel short peptides that inhibit the opening of mammalian tight junctions
US7923373B2 (en)	2007-06-04	2011-04-12	Micron Technology, Inc.	Pitch multiplication using self-assembling materials
WO2008154493A2 (en) *	2007-06-07	2008-12-18	Alba Therapeutics Corporation	Novel peptides that inhibit the opening of mammalian tight junctions
WO2008154350A2 (en) *	2007-06-08	2008-12-18	Alba Therapeutics Corporation	Use of tight junction agonists to suppress immune responses
US20110201543A1 (en) *	2007-06-29	2011-08-18	Blake Paterson	Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
WO2009015382A2 (en) *	2007-07-26	2009-01-29	Alba Therapeutics Corporation	Novel peptides that enhance tight junction permeability
US7682924B2 (en)	2007-08-13	2010-03-23	Micron Technology, Inc.	Methods of forming a plurality of capacitors
WO2009052489A2 (en) *	2007-10-19	2009-04-23	Alba Therapeutics Corporation	Novel inhibitors of mammalian tight junction opening
US9051349B2 (en)	2007-11-21	2015-06-09	Alba Therapeutics Corporation	Larazotide acetate compositions
EP2062909A1 (en) *	2007-11-21	2009-05-27	SOLVAY (Société Anonyme)	Peptide production and purification process
WO2009110947A2 (en) *	2007-12-19	2009-09-11	Alba Therapeutics Corporation	Compositions and methods for inhibiting cytokine production
US8388851B2 (en)	2008-01-08	2013-03-05	Micron Technology, Inc.	Capacitor forming methods
US8274777B2 (en)	2008-04-08	2012-09-25	Micron Technology, Inc.	High aspect ratio openings
WO2009137572A2 (en)	2008-05-06	2009-11-12	Alba Therapeutics Corporation	Inhibition of gliadin peptides
US7759193B2 (en)	2008-07-09	2010-07-20	Micron Technology, Inc.	Methods of forming a plurality of capacitors
JP2012529508A (ja) *	2009-06-10	2012-11-22	ユニバーシティオブメリーランド，ボルチモア	腸透過性のｅｇｆｒおよびｐａｒ２調節
RU2410765C1 (ru) *	2009-07-21	2011-01-27	Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию	Способ профилактики токсического действия никеля у экспериментальных животных при хроническом отравлении
RU2412489C1 (ru) *	2009-09-01	2011-02-20	Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию	Способ профилактики хронической токсической кардиопатии у экспериментальных животных
US8518788B2 (en)	2010-08-11	2013-08-27	Micron Technology, Inc.	Methods of forming a plurality of capacitors
US9076680B2 (en)	2011-10-18	2015-07-07	Micron Technology, Inc.	Integrated circuitry, methods of forming capacitors, and methods of forming integrated circuitry comprising an array of capacitors and circuitry peripheral to the array
US8946043B2 (en)	2011-12-21	2015-02-03	Micron Technology, Inc.	Methods of forming capacitors
KR102061486B1 (ko)	2012-03-19	2020-01-03	시다라 세라퓨틱스, 인코포레이티드	에키노칸딘 계열의 화합물에 대한 투여 용법
US8652926B1 (en)	2012-07-26	2014-02-18	Micron Technology, Inc.	Methods of forming capacitors
EP3066122B1 (en) *	2013-11-05	2021-04-14	Bio-Rad Laboratories, Inc.	Pre-haptoglobin-2 monoclonal antibodies and uses thereof
CN106456549A (zh) *	2014-04-04	2017-02-22	阿尔巴医疗公司	利用拉瑞唑来治疗乳糜泻的方法
US11058902B2 (en)	2017-02-10	2021-07-13	9 Meters Biopharma, Inc.	Compositions and methods for treating disease associated with permeability of intestinal epithelium
WO2019165346A1 (en)	2018-02-23	2019-08-29	Innovate Biopharmaceuticals, Inc.	Compounds and methods for treating tight junction permeability
EP4326304A1 (en)	2021-04-19	2024-02-28	Ebris S.r.l.	Zonulin antagonists for the treatment of multisystem inflammatory syndrome in children (mis-c) and adults (mis-a)
CN118873629B (zh) *	2024-09-27	2024-12-10	北京大学口腔医学院	醋酸拉唑肽在制备促进成骨药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US667048A (en) *	1900-07-06	1901-01-29	Edson F Whitman	Torpedo-projectile.
US2419898A (en)	1943-12-10	1947-04-29	Int Harvester Co	Shelled corn saver for husking devices
US5395750A (en) *	1992-02-28	1995-03-07	Hoffmann-La Roche Inc.	Methods for producing proteins which bind to predetermined antigens
WO1994011505A1 (en) *	1992-11-10	1994-05-26	Washington University	Pars planitis specific polypeptides
WO1994011508A2 (en) *	1992-11-13	1994-05-26	Cancer Research Fund Of Contra Costa	Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods
WO1994011509A2 (en) *	1992-11-16	1994-05-26	Cancer Research Fund Of Contra Costa	Peptides and anti-sense peptides with broad neoplastic specificity
JP2996864B2 (ja) *	1994-03-30	2000-01-11	寳酒造株式会社	抗体可変領域ｄｎａ
US5665389A (en)	1995-05-24	1997-09-09	University Of Maryland At Baltimore	Oral dosage composition for intestinal delivery and method of treating diabetes
CO4600637A1 (es) *	1996-03-15	1998-05-08	Corixa Corp	Compuestos para inmunoterapia e inmunodiagnosis del cancer de prostata
US5912323A (en) *	1997-02-20	1999-06-15	University Of Maryland, Baltimore	Zonula occludens toxin receptors
US5945510A (en) *	1997-05-21	1999-08-31	University Of Maryland, Baltimore	Substantially pure zonulin, a physiological modulator of mammalian tight junctions
US6506577B1 (en) *	1998-03-19	2003-01-14	The Regents Of The University Of California	Synthesis and crosslinking of catechol containing copolypeptides
US6458925B1 (en) *	1998-08-03	2002-10-01	University Of Maryland, Baltimore	Peptide antagonists of zonulin and methods for use of the same
CN1228084C (zh) *	1998-09-14	2005-11-23	巴尔的摩马里兰大学	应用Zot或zonulin以抗原特异性方式抑制淋巴细胞增殖的方法
WO2001089551A1 (en) *	2000-05-19	2001-11-29	University Of Maryland, Baltimore	Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
US8034776B2 (en) *	2006-10-26	2011-10-11	Alba Therapeutics Corporation	Materials and methods for the treatment of celiac disease

1998
- 1998-08-03 US US09/127,815 patent/US6458925B1/en not_active Expired - Lifetime
1999
- 1999-07-28 WO PCT/US1999/016683 patent/WO2000007609A1/en not_active Ceased
- 1999-07-28 JP JP2000563294A patent/JP4822585B2/ja not_active Expired - Lifetime
- 1999-07-28 AT AT06006483T patent/ATE480252T1/de not_active IP Right Cessation
- 1999-07-28 ES ES99940809T patent/ES2267282T3/es not_active Expired - Lifetime
- 1999-07-28 CN CN998100315A patent/CN1217697C/zh not_active Expired - Lifetime
- 1999-07-28 KR KR1020017001503A patent/KR100610389B1/ko not_active Expired - Lifetime
- 1999-07-28 CA CA2338005A patent/CA2338005C/en not_active Expired - Lifetime
- 1999-07-28 AT AT99940809T patent/ATE329606T1/de active
- 1999-07-28 DE DE69931929T patent/DE69931929T2/de not_active Expired - Lifetime
- 1999-07-28 IL IL14108299A patent/IL141082A0/xx unknown
- 1999-07-28 DK DK99940809T patent/DK1102596T3/da active
- 1999-07-28 NZ NZ509579A patent/NZ509579A/en not_active IP Right Cessation
- 1999-07-28 HU HU0103321A patent/HU228079B1/hu unknown
- 1999-07-28 AU AU54590/99A patent/AU745507B2/en not_active Expired
- 1999-07-28 CN CNB2005100077127A patent/CN100348266C/zh not_active Expired - Lifetime
- 1999-07-28 DE DE69942753T patent/DE69942753D1/de not_active Expired - Lifetime
- 1999-07-28 RU RU2001106615/14A patent/RU2214267C2/ru active
- 1999-07-28 EP EP99940809A patent/EP1102596B1/en not_active Expired - Lifetime
- 1999-07-28 EP EP06006483A patent/EP1698345B1/en not_active Expired - Lifetime
2001
- 2001-01-24 IL IL141082A patent/IL141082A/en not_active IP Right Cessation
- 2001-01-30 ZA ZA2001/00829A patent/ZA200100829B/en unknown
- 2001-02-02 NO NO20010567A patent/NO326552B1/no not_active IP Right Cessation
2002
- 2002-03-13 US US10/095,450 patent/US6670448B2/en not_active Expired - Lifetime
2003
- 2003-08-27 US US10/648,642 patent/US6936689B2/en not_active Expired - Lifetime
2005
- 2005-03-09 US US11/074,727 patent/US7189696B2/en not_active Expired - Fee Related
2006
- 2006-08-08 US US11/500,429 patent/US7531504B2/en not_active Expired - Fee Related
2007
- 2007-08-21 US US11/842,738 patent/US20090082279A1/en not_active Abandoned
- 2007-08-21 US US11/842,763 patent/US7582603B2/en not_active Expired - Fee Related
2010
- 2010-10-20 US US12/908,709 patent/US20110183923A1/en not_active Abandoned
2013
- 2013-01-09 US US13/737,517 patent/US20130190247A1/en not_active Abandoned
- 2013-11-01 US US14/070,208 patent/US20140128328A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2214267C2 (ru)	2003-10-20
HU228079B1 (en)	2012-10-29
NO326552B1 (no)	2009-01-05
ZA200100829B (en)	2002-06-26
AU5459099A (en)	2000-02-28
ES2267282T3 (es)	2007-03-01
KR100610389B1 (ko)	2006-08-09
KR20010072245A (ko)	2001-07-31
DE69931929T2 (de)	2007-02-08
EP1698345B1 (en)	2010-09-08
US20020115825A1 (en)	2002-08-22
CN1217697C (zh)	2005-09-07
NO20010567D0 (no)	2001-02-02
US20110183923A1 (en)	2011-07-28
US20060276399A1 (en)	2006-12-07
US20140128328A1 (en)	2014-05-08
CN1679915A (zh)	2005-10-12
AU745507B2 (en)	2002-03-21
US6458925B1 (en)	2002-10-01
ATE480252T1 (de)	2010-09-15
NZ509579A (en)	2003-07-25
US7531504B2 (en)	2009-05-12
IL141082A0 (en)	2002-02-10
US20090082279A1 (en)	2009-03-26
US7582603B2 (en)	2009-09-01
EP1698345A2 (en)	2006-09-06
US20050209161A1 (en)	2005-09-22
DE69942753D1 (de)	2010-10-21
JP2002524393A (ja)	2002-08-06
EP1102596A1 (en)	2001-05-30
IL141082A (en)	2012-09-24
HK1082210A1 (zh)	2006-06-02
ATE329606T1 (de)	2006-07-15
DK1102596T3 (da)	2006-10-09
DE69931929D1 (de)	2006-07-27
US20130190247A1 (en)	2013-07-25
CN100348266C (zh)	2007-11-14
US6670448B2 (en)	2003-12-30
CN1313772A (zh)	2001-09-19
EP1102596A4 (en)	2002-08-14
HUP0103321A2 (hu)	2001-12-28
EP1698345A3 (en)	2006-09-13
US7189696B2 (en)	2007-03-13
CA2338005C (en)	2012-05-29
JP4822585B2 (ja)	2011-11-24
EP1102596B1 (en)	2006-06-14
WO2000007609A1 (en)	2000-02-17
US6936689B2 (en)	2005-08-30
CA2338005A1 (en)	2000-02-17
HUP0103321A3 (en)	2006-01-30
US20040082512A1 (en)	2004-04-29
US20080051349A1 (en)	2008-02-28

Publication	Publication Date	Title
NO20010567L (no)	2001-04-02	Zonulinpeptidantagonister og fremgangsmÕter for anvendelse av disse
TR199801255T2 (xx)	1998-10-21	Vitronektin resept�r antagonistleri.
TR199801253T2 (xx)	1998-12-21	Vitronektin resept�r� antagonistleri.
DE69731373D1 (de)	2004-12-02	Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
CY1107821T1 (el)	2013-06-19	Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
DK1053256T3 (da)	2011-10-03	Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
ZA978204B (en)	1998-03-03	Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR)
ATE196314T1 (de)	2000-09-15	Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
ATE270557T1 (de)	2004-07-15	Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
TR199700993T1 (xx)	1998-03-21	5-ikameli-3-(1,2,3,6-tetrahidropridin-4-il)- ve 3-(piperidin-4-il)-1H-indoller: yeni 5-HT1F agonistler.
GR3034267T3 (en)	2000-12-29	Domains of extracellular region of human platelet derived growth factor receptor polypeptides.
DK0982988T3 (da)	2004-01-19	I det væsentlige rent zonulin, en fysiologisk modulator af mammale tight junctions
ATE197307T1 (de)	2000-11-15	Neuroaktive peptide
TR200002896T2 (tr)	2001-01-22	Kalsilitik Bileşimler
DE69824719D1 (de)	2004-07-29	Cytokinähnlicher faktor-7 aus säugetieren
TR200100462T2 (tr)	2001-09-21	Muskarinik agonistleri ve antagonistleri
CO5460266A1 (es)	2004-11-30	Novedosos analogos de la somatostatina
TR200102041T2 (tr)	2001-12-21	Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar
NO986218L (no)	1998-12-30	FremgangsmÕte til Õ bestemme nµrvµr av hjerneprotein S-100
DK1022636T3 (da)	2005-02-07	Blandingsarmatur med etgrebsbetjening
DE69938130D1 (de)	2008-03-27	Neue peptide
EA200000875A1 (ru)	2001-10-22	Белки, взаимодействующие с каспазой-8
DE69526738D1 (de)	2002-06-20	Endothelin-rezeptor-antagonisten
ATE200678T1 (de)	2001-05-15	Urogenitalkarzinom tlp peptidkomplex und abgeleitete antikörper
TR199802387T2 (xx)	1999-03-22	Do�um kontrol� i�in kullan�lan Zona Pellucida proteinleri.

Legal Events

Date	Code	Title	Description
2019-08-12	MK1K	Patent expired